Clariness Announces Role in Supporting YPrime's Patient and Site eCOA Initiatives
Clariness announces its support of YPrime’s ongoing commitment to enhance the patient and site eCOA experience, by delivering insights from more than 2,000 patients, in four countries, assessing patient demographics and psychographics.
Assessing the digital behaviors and trial awareness of a diverse international population, Clariness received patient insights across five therapeutic areas, including oncology, immunology, rare diseases, central nervous system, and dermatology.
Clariness was tasked with providing insights from 1,600 patients, gathering data on digital device usage behaviors, app and notification preferences, and previous trial experiences. Clariness delivered insights from over 2,000 patients, in two months, which could be segmented by patient age, medical condition, education level, ethnicity, spoken language, and more.
Reference
Clariness delivers more than 50,000 patient data points to drive YPrime’s customer experience. (2023, April 24). Clariness.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
